1. Home
  2. LIDR vs ABP Comparison

LIDR vs ABP Comparison

Compare LIDR & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • ABP
  • Stock Information
  • Founded
  • LIDR 2013
  • ABP 2004
  • Country
  • LIDR United States
  • ABP United States
  • Employees
  • LIDR N/A
  • ABP N/A
  • Industry
  • LIDR Auto Parts:O.E.M.
  • ABP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIDR Consumer Discretionary
  • ABP Health Care
  • Exchange
  • LIDR Nasdaq
  • ABP Nasdaq
  • Market Cap
  • LIDR 14.8M
  • ABP 15.5M
  • IPO Year
  • LIDR N/A
  • ABP N/A
  • Fundamental
  • Price
  • LIDR $0.77
  • ABP $0.21
  • Analyst Decision
  • LIDR Hold
  • ABP Strong Buy
  • Analyst Count
  • LIDR 1
  • ABP 1
  • Target Price
  • LIDR N/A
  • ABP $4.00
  • AVG Volume (30 Days)
  • LIDR 463.9K
  • ABP 28.3M
  • Earning Date
  • LIDR 08-04-2025
  • ABP 05-15-2025
  • Dividend Yield
  • LIDR N/A
  • ABP N/A
  • EPS Growth
  • LIDR N/A
  • ABP N/A
  • EPS
  • LIDR N/A
  • ABP N/A
  • Revenue
  • LIDR $246,000.00
  • ABP $183,000.00
  • Revenue This Year
  • LIDR $2,677.23
  • ABP N/A
  • Revenue Next Year
  • LIDR $409.09
  • ABP N/A
  • P/E Ratio
  • LIDR N/A
  • ABP N/A
  • Revenue Growth
  • LIDR N/A
  • ABP 88.66
  • 52 Week Low
  • LIDR $0.49
  • ABP $0.15
  • 52 Week High
  • LIDR $4.30
  • ABP $11.19
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 58.46
  • ABP N/A
  • Support Level
  • LIDR $0.68
  • ABP N/A
  • Resistance Level
  • LIDR $0.84
  • ABP N/A
  • Average True Range (ATR)
  • LIDR 0.06
  • ABP 0.00
  • MACD
  • LIDR 0.00
  • ABP 0.00
  • Stochastic Oscillator
  • LIDR 60.70
  • ABP 0.00

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: